These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19998739)

  • 21. Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004.
    Haber P; Slade B; Iskander J
    Vaccine; 2007 Nov; 25(48):8101. PubMed ID: 17933441
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain-Barré syndrome and immunizations.
    Randall DP
    Dis Mon; 2010 May; 56(5):293-8. PubMed ID: 20493307
    [No Abstract]   [Full Text] [Related]  

  • 23. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination.
    Hoshino T; Uchiyama Y; Ito E; Osawa S; Ohashi T
    Intern Med; 2012; 51(12):1595-8. PubMed ID: 22728497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pandemic vaccines and small excess of Guillain-Barre cases.
    BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
    [No Abstract]   [Full Text] [Related]  

  • 25. Does informing patients of the risk of acquiring Guillain-Barré syndrome following influenza vaccination have an effect on their willingness to be vaccinated?
    De Wals P
    Can Commun Dis Rep; 2000 Dec; 26(23):205-7. PubMed ID: 11131690
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evidence of indications of influenza vaccine and its efficacy--including Guillain-Barré syndrome as an adverse reaction(?)].
    Watanabe A
    Nihon Rinsho; 2003 Nov; 61(11):1987-91. PubMed ID: 14619443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine].
    Siegrist CA
    Rev Med Suisse; 2010 Jan; 6(231):67-70. PubMed ID: 20196437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?
    Salmon DA; Vellozzi C; Chen RT; Halsey NA
    Expert Rev Clin Immunol; 2013 Sep; 9(9):795-7. PubMed ID: 24070041
    [No Abstract]   [Full Text] [Related]  

  • 29. Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
    Price LC
    BMJ; 2009 Sep; 339():b3577. PubMed ID: 19740925
    [No Abstract]   [Full Text] [Related]  

  • 30. Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?
    Nelson KE
    Am J Epidemiol; 2012 Jun; 175(11):1129-32. PubMed ID: 22582208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible link between flu jab and Guillain-Barré syndrome under investigation.
    Marwick C
    BMJ; 2003 Mar; 326(7390):620. PubMed ID: 12649232
    [No Abstract]   [Full Text] [Related]  

  • 32. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccine and Guillain-Barré syndrome: making informed decisions.
    Poland GA; Poland CM; Howe CL
    Lancet; 2013 Apr; 381(9876):1437-9. PubMed ID: 23622271
    [No Abstract]   [Full Text] [Related]  

  • 34. Guillain-Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506.
    Moon JS; Souayah N
    Liver Transpl; 2006 Oct; 12(10):1537-9. PubMed ID: 17004261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaccination against influenza and Guillain-Barre syndrome: are there any relations?].
    Wiercińska-Drapało A; Grzeszczuk A; Wasilewski K; Prokopowicz D
    Pol Merkur Lekarski; 2000 May; 8(47):360-1. PubMed ID: 10944963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guillain-Barré syndrome after exposure to influenza].
    Hartung HP; Keller-Stanislawski B; Hughes RA; Lehmann HC
    Nervenarzt; 2012 Jun; 83(6):714-30. PubMed ID: 22528062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global Advisory Committee on Vaccine Safety, December 2012.
    Wkly Epidemiol Rec; 2013 Feb; 88(6):65-72. PubMed ID: 23424731
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive value of surveillance case definitions of Guillain-Barré Syndrome in vaccine safety assessment.
    MSMR; 2012 Mar; 19(3):8-9. PubMed ID: 22452715
    [No Abstract]   [Full Text] [Related]  

  • 39. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 40. Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
    Salmon DA; Dudley MZ; Carleton BC
    J Infect Dis; 2021 Feb; 223(3):355-358. PubMed ID: 33137189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.